4//SEC Filing
Kristal Robert Eugene 4
Accession 0001021771-24-000048
CIK 0001505497other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:17 PM ET
Size
8.7 KB
Accession
0001021771-24-000048
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2024-02-13+263,158→ 263,158 totalExercise: $1.45Exp: 2034-02-13→ Common Stock (263,158 underlying)
Holdings
- 7,994
Common Stock
- 10,490
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (10,490 underlying) - 88,968
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (88,968 underlying)
Footnotes (3)
- [F1]The option is currently exercisable.
- [F2]The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
- [F3]The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.
Documents
Issuer
BioRestorative Therapies, Inc.
CIK 0001505497
Entity typeother
Related Parties
1- filerCIK 0001893955
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:17 PM ET
- Size
- 8.7 KB